UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934 (Amendment No. )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐	Preliminary Proxy Statement
☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☒	Definitive Proxy Statement
☐	Definitive Additional Materials
☐	Soliciting Material Pursuant to Section §240.14a-12

Kopin Corporation

(Name of Registrant as Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒	No fee required

☐	Fee paid previously with preliminary materials.

☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

KOPIN CORPORATION

125 North Drive, Westborough, Massachusetts 01581

April 20, 2026

To Our Stockholders:

You are cordially invited to attend the 2026 Annual Meeting of Stockholders of KOPIN CORPORATION, to be held at the offices of Morgan, Lewis & Bockius LLP, One Federal Street, Boston, Massachusetts 02110 at 10:00 a.m. Eastern Time on Thursday, May 21, 2026 (the “Meeting”).

The Notice of Meeting and the Proxy Statement that follow describe the business to be considered and acted upon by the stockholders at the Meeting. Our Annual Report on Form 10-K for the fiscal year ended December 27, 2025, as amended, is also enclosed for your information. The enclosed proxy statement is being mailed to stockholders of record on or about April 20, 2026.

Our Board of Directors encourages your participation in Kopin Corporation’s electoral process and, to that end, solicits your proxy with respect to the matters described in the Notice of Meeting and the Proxy Statement. You may submit your proxy by completing, dating and signing the enclosed Proxy Card and returning it promptly in the enclosed envelope. You may also vote by telephone or by the Internet, as described in the Proxy Statement. You are urged to vote by mail, telephone or Internet even if you plan to attend the Meeting.

	Sincerely,

	/s/ Michael Murray
	Chairman

KOPIN CORPORATION

125 North Drive, Westborough, Massachusetts 01581

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

To Be Held On Thursday, May 21, 2026

Notice is hereby given that the 2026 Annual Meeting (the “Meeting”) of Stockholders of Kopin Corporation (the “Company”) will be held at the offices of Morgan, Lewis & Bockius LLP, One Federal Street, Boston, Massachusetts 02110, on Thursday, May 21, 2026, at 10:00 a.m. Eastern Time, to consider and act upon the following matters:

	1.	To elect the five (5) directors named in the accompanying proxy statement to serve on the Board of Directors of the Company each for a term expiring at the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified.
	2.	To approve the amendment and restatement of the Company’s 2020 Equity Incentive Plan.
	3.	To ratify the appointment of BDO USA, P.C. (BDO) as the independent registered public accounting firm of the Company for the current fiscal year ending December 26, 2026.
	4.	To approve, on an advisory basis, the compensation of the Company’s named executive officers during the fiscal year ended December 27, 2025.

Stockholders of record at the close of business on Thursday March 26, 2026, the record date for the Meeting, are entitled to notice of and to vote at the Meeting and any adjournments thereof. The enclosed proxy statement is being mailed to those stockholders on or about April 20, 2026. All stockholders are cordially invited to attend the Meeting.

	By Order of the Board of Directors

	/s/ MICHAEL MURRAY
	Chairman

Westborough, Massachusetts

April 20, 2026

WHETHER OR NOT YOU EXPECT TO BE PRESENT AT THE MEETING, PLEASE COMPLETE, DATE, SIGN AND MAIL THE ENCLOSED PROXY CARD, WHICH IS SOLICITED BY THE BOARD OF DIRECTORS OF THE COMPANY, AND PROMPTLY RETURN IT IN THE PREADDRESSED ENVELOPE PROVIDED FOR THAT PURPOSE. THE ENCLOSED ENVELOPE REQUIRES NO POSTAGE IF MAILED IN THE UNITED STATES. ALTERNATIVELY, YOU MAY VOTE BY TELEPHONE OR THE INTERNET AS DESCRIBED IN THE PROXY STATEMENT. IF YOU ATTEND THE MEETING, YOU MAY WITHDRAW ANY PROXY PREVIOUSLY GIVEN BY YOU AND YOU MAY VOTE YOUR SHARES IN PERSON AT THE MEETING.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

The proxy statement may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are subject to the safe harbor created by such sections. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “could,” “would,” “seeks,” “estimates,” and variations of such words and similar expressions, and the negatives thereof, are intended to identify such forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that could cause our actual results to differ materially from the forward-looking statements expressed or implied in the proxy statement. Such risks, uncertainties and other factors include those risks described in “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (“SEC”) and other subsequent documents we file with the SEC. The Company expressly disclaims any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law.

Websites and Other Information

Website addresses referenced in this proxy statement inactive textual references only, and the content on the referenced websites specifically does not constitute a part of this proxy statement and is not incorporated by reference herein.

125 North Drive

Westborough, Massachusetts 01581

PROXY STATEMENT

Important Notice Regarding Internet Availability of Proxy Materials for the Stockholders Meeting to be Held at the Offices of Morgan, Lewis & Bockius LLP, One Federal Street, Boston, Massachusetts 02110 on Thursday, May 21, 2026, at 10:00 a.m. Eastern Time. The Proxy Statement and our 2025 Annual Report to Stockholders are also available on our website at www.kopin.com/proxy.

This proxy statement and the accompanying proxy card are being furnished in connection with the solicitation by the Board of Directors (the “Board”) of Kopin Corporation (the “Company”) for use at the 2026 Annual Meeting of Stockholders (the “Meeting”) to be held at the offices of Morgan, Lewis & Bockius LLP, One Federal Street, Boston, Massachusetts 02110 on Thursday, May 21, 2026, at 10:00 a.m Eastern Time., and at any adjournments, continuations or postponements thereof. This proxy statement, the accompanying proxy card and our Annual Report for the fiscal year ended December 27, 2025, are being first mailed to stockholders on or about April 20, 2026. Stockholders will be asked to consider and act upon the following matters at the Meeting:

	1.	To elect the five (5) directors to serve on the Board of Directors of the Company each for a term expiring at the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified.

	2.	To approve the amendment and restatement of the Company’s 2020 Equity Incentive Plan.

	3.	To ratify the appointment of BDO. as the independent registered public accounting firm of the Company for the current fiscal year ending December 26, 2026.

	4.	To approve, on an advisory basis, the compensation of the Company’s named executive officers during the fiscal year ended December 27, 2025.

All solicitation expenses, including costs of preparing, assembling and mailing proxy materials, will be borne by the Company. It is expected that solicitations will be made primarily by mail, but our directors, officers and other employees also may solicit proxies by telephone and in person, without additional compensation. Arrangements will be made with brokerage houses and other custodians, nominees and fiduciaries for proxy materials to be sent to their principals, and we will reimburse such persons for their reasonable expenses in so doing.

The close of business on Thursday, March 26, 2026, has been established as the record date for determining the stockholders entitled to notice of and to vote at the Meeting and at any adjournments thereof. As of the record date, there were 183,476,366 shares of our common stock and 1,000 shares of Series A convertible preferred stock issued and outstanding and entitled to vote. Holders of shares of our common stock are entitled to one vote for each common share owned as of the record date on all matters to come before the Meeting and any adjournments thereof. The holders of the Series A convertible preferred stock are entitled to vote as a single class with the holders of the Company’s common stock with one vote for each share of common stock that the preferred stock is convertible into. As of the record date, the issued and outstanding Series A convertible preferred stock were convertible into 2,333,333 shares of our common stock. The presence in person or by proxy of the holders of a majority of the stock issued and outstanding and entitled to vote thereat at the Meeting constitutes a quorum for the transaction of business at the Meeting.

Stockholders may vote by completing the enclosed proxy card and mailing it in the envelope provided, by using the toll-free telephone number provided on the proxy card, over the Internet or in person at the Meeting. The Internet and telephone voting facilities for stockholders of record will close at 11:59 p.m. Eastern Time on Wednesday, May 20, 2026, the day before the Meeting. Any proxy submitted prior to the Meeting may be revoked at any time before it is voted by written notice of revocation received by the Secretary of the Company prior to the Meeting, by delivering a later dated proxy in accordance with the instructions on the enclosed proxy by voting in person at the Meeting or by revoking a written proxy by request in person at the Meeting. If the proxy submitted is not so revoked, the shares represented by such proxy will be voted in accordance with the instructions contained therein. If no choice is specified for one or more proposals in a proxy submitted by or on behalf of a stockholder, the shares represented by such proxy will be voted in favor of such proposals and in the discretion of the named proxies with respect to any other proposals that may properly come before the Meeting.

For Proposal 1, our Sixth Amended and Restated By-laws (the “By-laws”) provide a majority voting standard for election of directors in uncontested elections. Each director will be elected by the affirmative vote of a majority of the votes cast, meaning that the number of votes cast “FOR” a director nominee exceeds the number of “AGAINST” votes with respect to that director’s election. Broker non-votes and abstentions will have no effect on the outcome of the vote for Proposal 1. Pursuant to our By-laws, each person who is nominated to stand for election as director must tender an irrevocable and executed letter of resignation in advance of the meeting for the election of directors. If an incumbent director nominee is not elected in an uncontested election and no successor has been elected at such meeting, the director must promptly tender his or her resignation to the Board. The Nominating and Corporate Governance Committee of the Board (excluding the nominee, if applicable) then will make a recommendation to the Board as to whether to accept or reject the resignation, or whether other action should be taken. The Board, excluding the nominee, will act on the resignation and publicly disclose its decision in accordance with the By-laws.

Proposals 2, 3 and 4 will be approved upon the affirmative vote of a majority of the shares present in person or represented by proxy at the Meeting and entitled to vote on each such proposal. Abstentions will be counted for each of Proposals 2, 3 and 4, and will have the same effect as a vote against each such proposal. Broker non- votes, if any, will have no effect on the outcome of the vote of Proposals 2, 3 or 4. However, Proposal 3, the ratification of the appointment of BDO as our independent registered public accounting firm, is considered a “routine” matter. As such, brokers that have not received voting instructions from the beneficial holders are allowed to vote their clients’ shares on Proposal 3 without having received voting instructions.

If, in a proxy submitted on behalf of a stockholder by a person acting solely in a representative capacity, the proxy is marked clearly to indicate that the shares represented thereby are not being voted with respect to one or more proposals, then such proxies will be counted as present for purposes of establishing a quorum at the Meeting. Proxies marked as “abstain” as to one or more proposals will be counted as present for purposes of establishing a quorum at the Meeting and for the purpose of calculating the vote on such proposals. Such abstentions will have the effect of a vote against such proposals other than Proposal 1 (for which they will have no effect on the voting results).

The chairman of the Meeting or the holders of a majority of the stockholders present in person or represented by proxy at the Meeting and entitled to vote have the power to adjourn the Meeting from time to time without notice other than announcement at the Meeting of the time and place of the adjourned meeting.

As of the date of this proxy statement, we do not know of any matters that will be brought before the Meeting other than those matters specifically set forth in the Notice of Annual Meeting of Stockholders. However, if any other matter properly comes before the Meeting, it is intended that the persons named as proxies in the enclosed proxy card, or their substitutes acting thereunder, will vote on any such matter in accordance with their best judgment.

Corporate Governance Matters

Our Board has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. The following table lists each of our current directors and provides membership information for each of the committees:

Name	Audit	Compensation	Nominating and Corporate Governance
Jill J. Avery±	X	X	X
Michael Murray
David Nieuwsma	X	X
Margaret Seif+#		X	X
Paul V. Walsh, Jr.*.	X		X

±	Lead Independent Director
+	Compensation Committee Chairperson
#	Nominating Committee Chairperson
*	Audit Committee Chairperson

Corporate Governance Guidelines

Our Board has adopted written charters for each of its Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee. Our Board has also adopted corporate governance guidelines, a code of business conduct and ethics for employees, executive officers and directors, a policy on conflict minerals sourcing and a whistleblower policy regarding the treatment of complaints on accounting, internal accounting controls and auditing matters. All of these documents are available on our website at www.kopin.com under the heading “Investors Relations: Governance Documents.” A copy of any of these documents may be obtained, without charge, upon written request to Kopin Corporation, c/o Investor Relations, 125 North Drive, Westborough, MA 01581.

Corporate Governance Practices and Board Independence

Each year, our Board reviews the relationships that each director has with us and with other parties. With the exception of Michael Murray, our current Chairman of the Board, President and Chief Executive Officer, only those directors who do not have any of the categorical relationships that preclude them from being independent within the meaning of applicable Nasdaq Stock Market, Inc. Marketplace Rules (the “Nasdaq Rules”), and whom the Board affirmatively determines have no relationships that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director, are considered to be independent directors. Our Board has reviewed several factors to evaluate the independence of each of its members. These factors include the members’ current and historic relationships with us and our competitors, suppliers and customers; their relationships with management and other directors; the relationships their current and former employers have with us; and the relationships between us and other companies of which a member of our Board is a director or executive officer. After evaluating these factors, our Board has determined that a majority of the current members of the Board and director nominees, namely, Jill J. Avery, Margaret Seif, David Nieuwsma, and Paul V. Walsh, Jr. do not have any relationships that would interfere with the exercise of independent judgment in carrying out their responsibilities as a director and are independent directors of Kopin Corporation within the meaning of the applicable Nasdaq Rules.

In making its independence determinations, our Board considered transactions occurring since the beginning of 2023 between us and entities associated with the independent directors or members of their immediate family. All identified transactions that appear to relate to Kopin Corporation and a person or entity with a known connection to a director are presented to the Board for consideration. In making its subjective determination that each non-employee director is independent, our Board considered the transactions in the context of the Nasdaq Rules, the standards established by the SEC for members of audit committees and the SEC and Internal Revenue Service standards for compensation committee members.

Nomination and Election of Directors

When seeking candidates for director, the Nominating and Corporate Governance Committee (the “Nominating Committee”) may solicit suggestions from incumbent directors, management or others. After conducting an initial evaluation of a candidate, the Nominating Committee will interview that candidate if it believes the candidate might be suitable to serve as a director. The Nominating Committee may also ask the candidate to meet with our management. If the Nominating Committee believes a candidate would be a valuable addition to the Board and there is either a vacancy on the Board or the Nominating Committee believes it is in the best interests of Kopin Corporation and its stockholders to increase the number of board members, it will recommend that candidate’s election to the full Board.

Before nominating a sitting director for re-election at an annual stockholder meeting, the Nominating Committee will consider the director’s performance on the Board and whether the director’s re-election would be consistent with our corporate governance guidelines and our continued compliance with applicable laws, rules and regulations.

Our Board believes that it should be comprised of directors with a diversity of skills, experiences, abilities, views and perspectives, and that directors should have expertise that, at a minimum, will be useful to us and will contribute to the success of our business. Directors also should possess the highest personal and professional ethics and should be willing and able to devote an amount of time sufficient to effectively carry out their duties and contribute to the success of our business. When considering candidates for director, the Nominating Committee takes into account a number of factors, which may include the following:

	●	Independence from management;

	●	Background;

	●	Relevant business experience;

	●	Judgment, skill and integrity;

	●	Existing commitments to other businesses;

	●	Potential conflicts of interest;

	●	Corporate governance background;

	●	Financial and accounting background;

	●	Executive compensation background; and

	●	Size and composition of the existing Board.

Stockholder Proposals

The Nominating Committee will consider candidates for director suggested by stockholders by considering the foregoing criteria and the additional information referred to below. Stockholders wishing to suggest a candidate for director should write to Kopin Corporation, c/o Investor Relations, 125 North Drive, Westborough, MA 01581, and include the following:

	●	The name and address of the stockholder and a statement that he, she, they or it is one of our stockholders and is proposing a candidate for consideration by the Nominating Committee;

	●	The class and number of shares of our capital stock owned by the stockholder as of the record date for the annual stockholder meeting (if such date has been announced) and as of the date of the notice, and length of time such stockholder has held such shares;

	●	The name, age and address of the candidate;

	●	A description of the candidate’s business and educational experience;

	●	The class and number of shares of our capital stock, if any, owned by the candidate, and length of time such candidate has held such shares;

	●	Information regarding each of the foregoing criteria the Board generally considers, other than the factors regarding Board size and composition, sufficient to enable the committee to evaluate the candidate;

	●	A description of any relationship between the candidate and any of our customers, suppliers or competitors or any actual or potential conflict of interest;

	●	A description of any relationship or understanding between the stockholder and the candidate; and

	●	A written statement by the candidate that the candidate is willing to be considered and willing to serve as a director if nominated and elected.

Time for Submission of Stockholder Proposals

Under our By-laws, nominations for directors may be made only by or at the direction of the Board, or by a stockholder of record at the time of giving notice who is entitled to vote and delivers written notice to the Secretary of the Company at its principal executive offices at 125 North Drive, Westborough Massachusetts, 01581 along with the additional information and materials required by our By-laws not less than 90 days and not more than 120 days prior to the first anniversary of the preceding year’s annual meeting. For our annual meeting in the year 2027, we must receive this notice no earlier than January 21, 2027, and no later than February 20, 2027 to be eligible for consideration at the annual meeting in 2027. You can obtain, without charge, a copy of the by-laws by writing to Kopin Corporation, c/o Investor Relations, 125 North Drive, Westborough, MA 01581.

Under our By-laws, stockholders may present proposals other than director nominations that may be proper subjects for inclusion in the proxy statement and for consideration at an annual meeting. For business to be properly brought before a stockholder meeting by a stockholder, the stockholder must have given timely notice thereof in writing to the Secretary. To be timely, a stockholder’s notice shall be delivered to or mailed and received at the principal executive offices of the Company at 125 North Drive, Westborough Massachusetts, 01581, not less than 30 days nor more than 75 days prior to the first anniversary of the preceding year’s annual meeting. For our annual meeting in the year 2027, pursuant to the requirements of our By-laws, we must receive such notice no earlier than March 7, 2027 and no later than April 21, 2027 to be eligible for consideration at the annual meeting in 2027.

Under Rule 14a-8 of the Securities and Exchange Act stockholders must deliver proposals to Kopin Corporation not later than December 21, 2026 if the proposal is submitted for inclusion in our proxy materials for the annual meeting in 2027.

In addition, stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must comply with the additional requirements of Exchange Act Rule 14a-19.

Stockholder Communications with the Board

The Board has established a process for stockholders to send communications to our Board or any individual director. Stockholders may send written communications to the Board or any director to Kopin Corporation, Board of Directors, c/o Chief Financial Officer, 125 North Drive, Westborough, MA 01581.

Related Party Transactions

The Audit Committee reviews and approves certain transactions or relationships involving Kopin and its directors, executive officers and their affiliates. Kopin has adopted policies and procedures that apply to any transaction or series of transactions in which Kopin, or a subsidiary, is a participant, the amount involved exceeds $120,000 and a related person has a direct or indirect material interest. In reviewing a transaction or relationship, the Audit Committee will take into account, among other factors it deems appropriate, the nature and terms of the transaction, the dollar value of the transaction, the business reasons for the transaction, whether it is on terms no more favorable than to an unaffiliated third party under similar circumstances, as well as the extent of the related party’s interest in the transaction. Our Code of Business Conduct and Ethics for Employees, Executive Officers and Directors prohibits any transaction or relationship that would create a conflict of interest, unless approved by the Board. Conflicts of interest are to be reported to the applicable employees’ immediate supervisor or to our Chief Financial Officer.

We do not currently provide personal loans to our executive officers or directors. Other than Proposal 1, none of our directors, executive officers or their associates have a substantial interest in any of the matters to be acted upon at the Meeting.

PROPOSAL 1

ELECTION OF DIRECTORS

Our By-laws provide that the Board shall consist of not less than three nor more than 13 directors. At the Meeting, proxies cannot be voted for a greater number of individuals than the five nominees named in this Proxy Statement. Unless authority is withheld, it is the intention of the persons voting under the enclosed proxy to vote such proxy in favor of the election of each of the nominees to serve as director until the 2027 Annual Meeting of Stockholders and until their respective successors are elected and qualified. If any nominee is unavailable or unwilling to serve, such votes will be cast by the proxies either for a substitute nominee selected by the proxies or to fix the number of directors at a lesser number. Our Board currently has no reason to expect that any of the nominees will be unavailable or unwilling to serve. Each of the nominees has consented to being named in this proxy statement and to serve if elected.

Vote Required for Election

The election of directors requires a majority voting standard for election of directors in uncontested elections. Each director will be elected by the affirmative vote of a majority of the votes cast, meaning that the number of votes cast “FOR” a director nominee exceeds 50% of the number of votes cast with respect to that director’s election. Any “non-votes” and abstentions from voting received will have no effect on the outcome of this Proposal 1. Directors are elected by plurality vote in a contested election of directors (as defined in our By-laws).

Pursuant to our By-laws, each person who is nominated to stand for election as director must tender an irrevocable and executed letter of resignation in advance of the Meeting for the election of directors. If an incumbent director nominee is not elected by a majority of the votes cast in an uncontested election and no successor has been elected at such meeting, the director must promptly tender his or her resignation to the Board. The Nominating Committee (excluding the nominee, if applicable) then will make a recommendation to the Board as to whether to accept or reject the resignation, or whether other action should be taken. The Board, excluding the nominee, will act on the resignation and publicly disclose its decision in accordance with the By- laws.

The Board of Directors has nominated and recommends that you vote “FOR” the election of each of the nominees listed below to serve as our Directors until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified.

Our Board of Directors (the “Board”) currently consists of five (5) members: Michael Murray, Jill Avery, David Nieuwsma, Margaret Seif, and Paul V. Walsh, Jr. Set forth below are the name and age for each director nominee, his or her principal occupation and business experience during the past five years and the names of other publicly-traded companies of which he or she served as a director.

Name	Age		Served as Director Since		Position and Offices with the Company
Jill J. Avery		58		2021	Lead Independent Director
Michael Murray		51		2022	President and Chief Executive Officer, Director
David Nieuwsma		62		2023	Director
Margaret Seif		65		2024	Director
Paul V. Walsh, Jr.		61		2024	Director

Jill J. Avery – Dr. Avery has over 30 years of experience in marketing and brand management as well as management. Her expertise in marketing provides a complementary skillset to the technical, operational, financial and legal experience of our other Board members.

Michael Murray – Mr. Murray has served as our Chief Executive Officer and President since September 2022. Mr. Murray is an engineer by training and previously served as President of the Cyber businesses of Ultra Electronics Group (Ultra), working with defense ministries and governments. Throughout his career, Mr. Murray has been associated with technology-focused companies where he was involved in the overall strategy of the business, product development, manufacturing, sales and marketing and acquisitions.

David Nieuwsma – Mr. Nieuwsma, a former US Air Force officer, had a 32-year career with Collins Aerospace where he held numerous roles including Executive Vice President, Information Management Solutions, President, Interior Solutions and President, Avionics Solutions. During his career, Mr. Nieuwsma accumulated a broad range of experience in engineering leadership, product line management, sales, marketing and strategy development. A significant portion of Kopin’s revenues is derived from the sale of our products for defense applications and Mr. Nieuwsma brings a deep understanding of our end markets, customers and U.S. Department of Defense procurement.

Margaret Seif – From 2006 to 2022, Ms. Seif served in a variety of C suite roles at Analog Devices, Inc. a leading semiconductor manufacturer. She brings extensive experience in mergers and acquisitions, talent strategy, intellectual property strategy, governance and risk management to the Board.

Paul V. Walsh, Jr. – Mr. Walsh is qualified to serve as a member of the Board because his extensive experience of more than 30 years in the global semiconductor industry, Previously, Mr. Walsh with served as Chief Financial Officer for two public companies in the global semiconductor industry. We believe this experience provides our Board with valuable executive-level insights and broad and diverse operational industry experience.

The Board considers diversity in terms of education, business experience and reputation when considering candidates for our Board. There are no family relationships among any of our directors, officers or director nominees.

Background of Nominees for Director and Certain Officers

Nominees

Jill J. Avery, Director. Dr. Avery has served as one of our directors since 2021. Dr. Avery is a Senior Lecturer of Business Administration and C. Roland Christensen Distinguished Management Educator in the marketing unit at Harvard Business School, a position she has held since 2013. She is an authority on brand management, customer relationship management (CRM), and digital marketing. Prior to her academic career, she worked in consumer packaged goods brand management, managing brands for The Gillette Company, Braun Inc., Samuel Adams, and AT&T, and spent time on the agency side of the business, as an Account Executive managing consumer promotions for Pepsi, General Foods, Bristol-Myers, and Citibank. She is Lead Director of the Board at Amica Mutual Insurance Company, a Director of the Harvard/MIT COOP, President Emerita of the Board of Trustees at the Museum of Fine Arts, Boston, and a Trustee of the Boston Ballet. Dr. Avery holds a D.B.A. in marketing from Harvard Business School, a M.B.A in marketing and finance from the Wharton School, and a B.A. in English from the University of Pennsylvania. During the past five years, Dr. Avery has not served on the board of directors of any other public companies or registered management investment companies.

Michael Murray President, Chief Executive Officer, Director. Mr. Murray has served as one of our directors since 2022. Mr. Murray joined Kopin in September 2022 from Ultra, a British Defense and Security company he joined in 2020, where he served as President of the Cyber business. Prior to joining Ultra, Mr. Murray worked at Blackridge Technology as a Senior Vice President and General Manager, IloT from 2017 to 2020. An engineer by training, Mr. Murray has always been associated with technology-focused companies. Prior to Ultra Electronics, he worked at Aceinna Inc. as Executive Vice President and Analog Devices, where he led the Industrial Sensing business unit. At these companies Mr. Murray was involved in overall strategy of the business, product development, manufacturing, sales and marketing and acquisitions. Mr. Murray holds a B.S.C. in business management from Northeastern University, a M.S.C in technology commercialization from Northeastern University, and a M.B.A from Massachusetts Institute of Technology. During the past five years, Mr. Murray has not served on the board of directors of any public companies or registered management investment companies.

David Nieuwsma, Director. Mr. Nieuwsma has served as one of our directors since November of 2023. A former US Air Force officer, he was employed with Collins Aerospace from 1991 to 2022. Mr. Nieuwsma led numerous lines of business at Collins Aerospace including roles as Executive Vice President, Information Management Solutions, President, Interior Solutions and President, Avionics Solutions. Mr. Nieuwsma holds a B.S., management from the US Air Force Academy in Colorado Springs, Colorado, a B.S., computer science, from Chapman College, Orange, California, and a M.B.A. from the University of Iowa. He spent five years in the US Air Force, completing his military career attaining the rank of Captain, as an Acquisition Project Officer, Ballistic Systems Division, Norton AFB, California. During the past five years, Mr. Nieuwsma has not served on the board of directors of any public companies or registered management investment companies.

Margaret Seif, Director. Ms. Seif has served as one of our directors since May 2024. From 2006 to 2022 Ms. Seif held various positions including Chief People Officer and Chief Legal Officer at Analog Devices, Inc. (ADI) a global leader in the design and manufacturing of analog, mixed signal, and DSP integrated circuits. In her roles at ADI Ms. Seif’s responsibilities included talent strategy, all legal matters, structuring and negotiating multiple mergers and acquisitions, corporate governance matters, developing cyber risk mitigation strategies and protections of ADI’s portfolio of intellectual property assets. From 1998 to 2005 Ms. Seif was Senior Vice President, Corporate Development and General Counsel & Secretary at RSA Security Inc. Ms. Seif has a B. A. from Brown University and a J.D. from the University of Michigan Law School. During the past five years, Ms. Seif served as Corporate Secretary of ADI.

Paul V. Walsh Jr., Director. Mr. Walsh has served as one of our directors since September 2024. He currently serves on the board of directors of Semtech Corporation (NASDAQ: SMTC), since April 2023, as Audit Committee Chair, and a member of the Nominating & Governance and Strategy & Technology Committees and Wolfspeed, Inc. (NYSE: WOLF), since May 2025, as Audit Committee Chair. Prior to retiring in February 2022, Mr. Walsh served as Chief Financial Officer, Senior Vice President and Treasurer, at Allegro MicroSystems, Inc. (NYSE: ALGM), a publicly traded global semiconductor company that designs and manufactures advanced sensor and power management integrated circuits for the automotive and industrial end markets, from 2014 to February 2022. Prior to joining Allegro, Mr. Walsh served as the Chief Financial Officer and Senior Vice President of Rocket Software, Inc., a global software development firm, from 2013 to 2014. From 2004 to 2013, he served in several financial leadership roles at Silicon Laboratories Inc., a publicly traded global technology company that designs and manufacturers semiconductors, including as: Chief Financial Officer and Senior Vice President from 2011 to 2013; and Chief Accounting Officer and Vice President of Finance from 2006 to 2011, among other roles. Additionally, he has served on the board of directors of Nitero, Inc., a venture-backed startup semiconductor company, from 2012 to 2015, Grande Communications Networks, LLC, a broadband communications provider of cable and internet services, from 2008 to 2010, including as chairman of Grande’s audit committee. Mr. Walsh graduated in 1986 with a B.S. in Mechanical Engineering from the University of Maine, an M.B.A from Boston University in 1992 and a Graduate Certificate in Accountancy from Bentley University in 1996. Mr. Walsh passed the CPA exam on the first attempt in May 1997.

Officers

Michael Murray, President, Chief Executive Officer, Director. Mr. Murray, age 52, has served as our President and Chief Executive Officer since September 6, 2022. Mr. Murray served as President of the Cyber business of Ultra Electronics Group, a British Defense and Security company. Prior to Ultra Electronics, he worked at Aceinna as Executive Vice President and Analog Devices, where he led the Industrial Sensing business unit.

Erich Manz, Treasurer and Chief Financial Officer. Mr. Manz, age 57, has served as our Treasurer and Chief Financial Officer since September 2025. Previously, Mr. Manz served as the Business Unit Chief Financial Officer of Allegro MicroSystems (NYSE: ALGM) where he led the financial structure, support, and oversight for the product business group from March 2023 to July 2025. Mr. Manz began his career at Serta in their accounting department and holds a B.S. in accounting from Bryant University.

Paul Baker, Chief Operating Officer for Kopin Government and Industrial and Strategic Business Officer. Mr. Baker, age 63, has served as the Company’s Chief Operating Officer for Kopin Government and Industrial and Strategic Business Officer since January 2020. Previously Mr. Baker served as the Company’s Strategic Business Officer from February 2019 to January 2020 Senior Vice President, Business Development from January 2017 to January 2019, and as Vice President, Business Development between March 2014 and December 2016. From 2007 to 2014, Mr. Baker served as Executive Vice President, Business Development & Sales at ZINK Imaging Co., a private company headquartered in Billerica, Massachusetts that invented ZINK Zero Ink® Technology. Mr. Baker holds a B.A. in economics from Colby College and an M.B.A. from Boston University.

Board Structure and Risk

Our Board leadership structure is commonly utilized by other public companies in the United States, and we believe that it is effective for us. We believe this leadership structure is appropriate for us given the size and scope of our business, the experience and active involvement of our independent directors, and our corporate governance practices, which include regular communication with and interaction between and among the Chief Executive Officer and the Chief Financial Officer and the independent directors. Pursuant to our By-laws, our Board selects the Chairman and the Chief Executive Officer that it determines to be in the best interest of our stockholders. Mr. Murray currently serves as both our principal executive officer and Chairman of the Board In addition, the Board elected Ms. Avery to serve as Lead Independent director in fiscal year 2025. Our Board has determined that each of Jill J. Avery, David Nieuwsma, Margaret Seif and Paul V. Walsh, Jr. are independent as that term is defined under the applicable independence listing standards of Nasdaq Rules and the applicable SEC rules and regulations.

We believe that our directors provide effective oversight of risk management functions. Annually, we perform a risk review where the management team evaluates the risks facing us in the upcoming year and over a longer-term horizon, typically three years. From this risk assessment, we develop plans to deal with the risks identified. This risk assessment is provided to the Board and their input is reflected in the annual risk assessment.

In addition, members of our management periodically present to the Board the strategies, issues and plans for the product lines they manage. The Compensation Committee also reviews our incentive plans to determine whether they result in management behavior that may result in additional risk beyond the plans’ intended purpose. While the Board oversees our risk management, our management is responsible for day-to-day risk management processes. Additionally, the Board requires that management raise exceptional issues to the Board. We believe this division of responsibilities is the most effective approach for addressing the risks facing us and that the Board leadership structure supports this approach.

Board and Committee Meetings

During fiscal year 2025, our Board held eleven (11) meetings. For each director that was voted to the Board at the 2025 Annual Meeting of Stockholders, overall attendance at Board meetings and relevant committee meetings, either in person or by conference call, was greater than 75% during the period they were on the Board or committee during fiscal year 2025. All directors attended the Company’s 2025 Annual Stockholder Meeting. Although we currently do not require our directors to attend annual stockholder meetings, we do encourage directors to do so and welcome their attendance.

Audit Committee: We have established a separately designated Audit Committee as defined by Section 3(a)(58)(A) of the Exchange Act. Our Audit Committee is composed of three directors: Paul V. Walsh, Jr., (Chairperson), Jill J. Avery, and David Nieuwsma, each of whom the Board has determined is independent under the Nasdaq Rules and the applicable SEC rules and regulations. The Board has determined that Mr. Walsh is an “audit committee financial expert” as defined by Item 407(d)(5)(ii) of Regulation S-K of the Exchange Act. Our Board adopted an Audit Committee Charter, which is available on our website at www.kopin.com under the heading “Investor Relations: Governance Documents.” Our Audit Committee Charter delegates to the Audit Committee the responsibility, among other things, to engage our independent auditors, review the audit fees, supervise matters relating to audit functions, review and set internal policies and procedure regarding audits, accounting and other financial controls and review related party transactions. The Audit Committee pre-approved all audit and non-audit services provided by BDO for fiscal year 2025. During the 2025 fiscal year, our Audit Committee met in person or through a conference call five times. Mr. Walsh and Ms. Avery attended four meetings, and Mr. Nieuwsma attended all five meetings.

Nominating and Corporate Governance Committee: Our Nominating and Corporate Governance Committee presently is composed of three directors: Margaret Seif (Chairperson), Jill Avery and Paul V Walsh, Jr., each of whom the Board has determined is independent under applicable SEC and Nasdaq Rules. The Nominating and Corporate Governance Committee is responsible for, among other things, considering potential Board members, making recommendations to the full Board as to nominees for election to the Board, assessing the effectiveness of the Board and implementing our corporate governance guidelines. The charter of the Nominating and Corporate Governance Committee is available on the Company’s website at www.kopin.com under the heading “Investor Relations: Governance Documents.” During the 2025 fiscal year, our Nominating and Corporate Governance Committee met in person or through a conference call two times and all members participated in the meetings. Ms. Seif and Dr. Avery participated in both meetings and Mr. Walsh was added to the Nominating and Corporate Governance Committee in June 2025 and participated in the one subsequent meeting.

Compensation Committee: Our Compensation Committee presently is composed of three directors: Margaret Seif (Chairperson), Jill Avery, and David. Nieuwsma, each of whom the board has determined is independent under applicable SEC and Nasdaq Rules. The charter of the Compensation Committee is available on our website at www.kopin.com under the heading “Investor Relations: Governance Documents.” During the 2025 fiscal year, our Compensation Committee met in person or through a conference call twelve times. Ms. Seif and Mr. Nieuwsma participated in all meetings and Dr. Avery was added to the Compensation Committee in June 2025 and participated in all nine subsequent meetings The Compensation Committee is responsible for the approval of remuneration arrangements for our executive officers, review and approval of compensation plans relating to executive officers and directors, including grants of stock options, restricted stock and stock grants under our 2020 Equity Incentive Plan and other benefits and general review of our employee compensation policies.

The information contained on the Company’s website at www.kopin.com is not considered incorporated by reference in this proxy statement. Compensation Committee Interlocks and Insider Participation.

None of our executive officers serves as a member of the board of directors or compensation committee, or other committee serving an equivalent function, of any other entity that has one or more of its executive officers serving as a member of our Board or Compensation Committee. None of the current members of our Compensation Committee has ever been an employee of Kopin or any subsidiary of Kopin.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The table below contains information, as of the dates below, regarding the beneficial ownership of all those known to us to be a beneficial owner of more than 5% of our common stock as well as our directors and nominees, named executive officers and all of our executive officers and directors as a group as of March 26, 2026. The address of each holder listed below, except as otherwise indicated, is 125 North Drive, Westborough, Massachusetts 01581.

Name and Address of Beneficial Owner	Amount and Nature of Beneficial Ownership⁽¹⁾		Percentage Ownership⁽²⁾
Directors and Named Executive Officers
Jill J. Avery		159,000		*
Michael Murray		3,119,042		1.7
David Nieuwsma		193,500		*
Margaret Seif		129,000		*
Paul V. Walsh, Jr.		129,000		*
Erich Manz		400,000		*
Paul Baker		596,865		*
Richard Sneider		610,277		*
All directors and executive officers as a group (7 persons)		4,726,407		2.6
5% or Greater Stockholders
BlackRock, Inc⁽³⁾		12,273,279		6.7
State Street Corporation⁽⁴⁾		11,119,885		6.1
Theon International, PLC.⁽⁵⁾		10,028,513		5.5
AWM Investment Company, Inc.⁽⁶⁾		18,314,500		9.9

*	Less than 1%

(1)	Unless otherwise indicated in these footnotes, each stockholder has sole voting and investment power with respect to the shares beneficially owned.
(2)	Percentages are based on 183,476,366 shares of our common stock outstanding as of March 26, 2026.
(3)	This information is based solely on information reported on Amendment No. 1 to a Schedule 13G filed on January 21, 2026 with the SEC on behalf of BlackRock, Inc., which reported sole voting power with respect to 12,101,307 shares of common stock, shared voting power with respect to 0 shares of common stock, sole dispositive power over with respect to 12,273,279 shares of common stock, and shared dispositive power with respect to 0 shares of common stock. The business address of BlackRock, Inc. is 50 Hudson Yards New York, NY 10001
(4)	This information is based solely on information reported on a Schedule 13G filed on February 9, 2026 with the SEC on behalf of State Street Corporation, which reported sole voting power with respect to 0 shares of common stock, shared voting power with respect to 10,898,507 shares of common stock, sole dispositive power with respect to 0 shares of common stock, and shared dispositive power with respect to 11,119,885 shares of common stock. The business address of State Street Corporation is One Congress Street, Suite 1, Boston, MA. 02114, United States.
(5)	This information is based solely on information reported on a Schedule 13G filed on November 6, 2025 with the SEC on behalf of Theon International, Plc. (“Theon”), Venetus Ltd (“Venetus”), CHRE Investments Ltd (“CHRE”), and Christianos Hadjiminas (“Hadjiminas”). Theon reported sole voting power with respect to 10,028,513 shares of common stock, shared voting power with respect to 0 shares of common stock, sole dispositive power over with respect to 10,028,513 shares of common stock, and shared dispositive power with respect to 0 shares of common stock. The sole voting power and sole dispositive power held by Theon consists of (i) 7,695,180 shares of common stock and (ii) 2,333,333 shares of common stock issuable upon the conversion of 1,000 shares of Series A Convertible Preferred Stock held by Theon. The voting power, dispositive power, and percentage of Theon’s beneficial ownership in class are based on the assumption that all 1,000 shares of Series A Convertible Preferred Stock held by Theon are converted into 2,333,333 shares of common stock. Each of Venetus, CHRE, and Hadjiminas reported sole voting power with respect to 10,128,513 shares of common stock, shared voting power with respect to 0 shares of common stock, sole dispositive power with respect to 10,128,513.00 shares of common stock, and shared dispositive power with respect to 0 shares of common stock. The sole voting power and sole dispositive power held by each of Venetus, CHRE, and Hadjiminas consists of (i) 7,695,180 shares of common stock and (ii) 2,333,333 shares of common stock issuable upon conversion of 1,000 shares of Series A Convertible Preferred Stock held by Theon, which is majority-owned by Ventus, and (iii) 100,000 shares of Common Stock held by Venetus Ltd. The voting power, dispositive power, and percentage of Venetus’s and CHRE’s beneficial ownership in class are based on the assumption that all 1,000 shares of Series A Convertible Preferred Stock held by Theon are converted into 2,333,333 shares of common stock. Hadjiminas is the sole shareholder of CHRE and has voting and dispositive control over CHRE. The voting power, dispositive power, and percentage of Hadjiminas’s beneficial ownership in class are based on the assumption that all 1,000 shares of Series A Convertible Preferred Stock held by Theon are converted into 2,333,333 shares of Common Stock. The business address of Theon International, Plc. is 5 Agiou Antoniou, Muskita Building 2, Office 102, 2002 Nocosia, Cyprus. The business address of Venetus and CHRE is 8 Kennedy & Atho St., Athienitis House 1087, Apt. 105, Agioi Omologites, Nicosia Cyprus. The business address of Hadjiminas is 7 Stratigi St., 15451, N. Psychiko, Greece.
(6)	The shares registered for resale hereby represent (i) 4,973,782 shares of Common Stock held directly by Special Situations Fund III QP, L.P.; (ii) 1,403,492 shares of Common Stock held directly by Special Situations Cayman Fund, L.P.; (iii) 525,279 shares of Common Stock held directly by Special Situations Private Equity Fund, L.P; (iv) 867,439 shares of Common Stock held directly by Special Situations Technology Fund, L.P.; and (v) 4,044,820 shares of Common Stock held directly by Special Situations Technology Fund II, L.P. AWM Investment Company, Inc. (“AWM”) is the investment adviser to each of the Special Situations Funds. In addition to the common stock of the Company held by AWM Investment Company Inc. they also own 10 million prefunded warrants which allow for the purchase of 10 million shares of the Company for $0.01 per share. The warrants include a 9.99% blocker. David Greenhouse and Adam Stettner are the principal owners of AWM. Through their control of AWM, Messrs. Greenhouse and Stettner share voting and investment control over the portfolio securities of each of the Special Situations Funds. Messrs. Greenhouse and Stettner disclaim any beneficial ownership of the reported shares other than to the extent of any pecuniary interest each of them may have therein. The address of AWM, each of the Special Situations Funds and Messrs. Greenhouse and Stettner is 527 Madison Avenue, Suite 2600, New York, NY 10022.

Delinquent Section 16(a) Reports

Section 16(a) of the Exchange Act requires the Company’s directors and executive officers, and persons who own more than 10% of a registered class of the Company’s equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company. Officers, directors and greater than 10% stockholders are required by SEC regulations to furnish the Company with copies of all Section 16(a) forms they file.

Based solely on a review of reports of ownership on Form 3 and changes in ownership on Forms 4 or 5 furnished to us and written representations from our directors and executive officers and other information, we believe that none of our directors, executive officers or 10% stockholders, failed to file on a timely basis the reports required to be filed pursuant to Section 16 of the Exchange Act during the fiscal year 2025 except for the following:

	i)	On October 23, 2025 Mr. Manz filed a Form 4 for his initial equity grant of 400,000 shares of the Company’s common stock which occurred on September 4, 2025. The Form 4 was late due to delays in obtaining his EDGAR filing codes.
	ii)	On January 8, 2026, Mr. Murray filed a Form 4 with respect to two transactions involving restricted stock units and options that were granted to him on January 5, 2026. The Form 4 was filed late due to an administrative oversight.
	iii)	On January 8, 2026, Mr. Baker filed a Form 4 with respect to a transaction involving restricted stock units that were granted to him on January 5, 2026. The Form 4 was filed late due to an administrative oversight.

COMPENSATION DISCUSSION AND ANALYSIS

The Company is considered a “smaller reporting company” under Item 10 of Regulation S-K promulgated under the Exchange Act and provides scaled compensation disclosure intended to comply with the requirements applicable to smaller reporting companies. Although the SEC guidance permits us to follow the rules applicable to a small reporting company for purposes of this proxy statement, we are committed to providing the compensation disclosure necessary to enable shareholders to understand our compensation plans, plan design and programs, as well as 2025 compensation decisions made by the Compensation Committee, and make informed voting decisions.

Named Executive Officers (NEOs)

Our NEOs for fiscal year 2025 were:

	●	Michael Murray, President and Chief Executive Officer (CEO)
	●	Erich Manz, Treasurer and Chief Financial Officer (CFO) commencing September 2, 2025
	●	Richard A. Sneider, Treasurer and Chief Financial Officer (CFO) terminating on September 1, 2025
	●	Paul Baker, Chief Operating Officer (COO)

Executive Summary

Provided below are key Company performance and executive compensation highlights for fiscal year 2025:

In 2025, we continued the reorganization of Kopin under a program we call One Kopin. In 2023, we started the process of creating one Business Development group that would sell all of Kopin’s products and one engineering group that would work on the design, development and manufacturing of all of Kopin’s products and in 2025 our strategic initiative began to produce results. Below is a summary of certain financial and development performance highlights that occurred in 2025 as a result of our strategic initiatives:

	●	$15.0 million strategic investment agreement entered into between the Company and Theon International Plc (Euronext Amsterdam: THEON), a globally recognized developer and manufacturer of advanced thermal imaging and night vision systems for global defense and thermal imaging markets to accelerate global defense innovation. This relationship provides us with the opportunity to enter the European NATO defense market, which is expected to grow significantly due to geopolitical issues, where we had had little presence in the past.

	●	We secured a transformative $15.4 million award to revolutionize color MicroLED technology and domestic production for U.S. Army Ground Soldier Integrated Visual Augmented Reality applications. This award marks a pivotal moment for Kopin, solidifying its leadership in MicroLED technology and establishing a robust U.S.-based production capability for this critical defense technology. The funding empowers Kopin to develop full-color MicroLED microdisplays tailored for Integrated Visual AR systems, in diverse lighting conditions-from intense daylight to low-visibility environments.

	●	In fiscal year 2025 we received orders of approximately $61 million. The orders we received in fiscal year 2025 are for eyepieces used in thermal weapon sights, displays used in fixed wing and rotary aircraft, training and simulation headsets, contracts for display and application specific optical solution design and development and follow on orders for our medical headset.

	●	We entered into a securities purchase agreement for a private investment in public equity financing that resulted in gross proceeds of approximately $41.0 million.

	●	To lead the Company to its next phase of growth, we appointed Erich Manz as Chief Financial Officer of the Company on August 7, 2025 and Iwan Dodd as Senior Vice President of Business Development of the Company on December 2, 2025.

Compensation Highlights:

Summarized below are highlights with respect to executive compensation for fiscal year 2025:

	●	Messrs. Murray and Baker received base wages increases from $495,000 to $512,000 and $334,000 to $354,000, respectively. Mr. Manz became the Company’s Chief Financial Officer on September 2, 2025 and his starting salary was set at $300,000. Prior to his retirement as Chief Financial Officer of the Company on May 29, 2025, Mr. Sneider received a base wage increase from $356,700 to $366,700.

	●	Mr. Murray was awarded performance bonus in fiscal year 2025 of $463,374 for his contribution to the Company’s fiscal year 2025 overall performance.

	●	Messrs. Murray, Baker and Sneider were awarded performance bonuses in fiscal year 2025 of $100,000, $30,000 and $10,000 respectively. The bonuses were related to the successful negotiation of the strategic agreement with Theon International PLC, the equity raise and certain other matters. Erich Manz received a $30,000 performance bonus for his contributions to the Company’s fiscal year 2025 results.

	●	Mr. Murray received a restricted stock grant of 408,634 which will cliff vest in January 2028. In addition, Mr. Murray received 591,366 option to purchase the Company’s common stock at a price of $1.76. 36,960 options vest each quarter through 2029. The vesting of the restricted stock and options are subject to the terms of the Company’s 2020 Equity Incentive Plan and the restricted stock and option agreements which include additional terms including a double trigger clause in the event of a change in control.

	●	Our primary objective for fiscal year 2025 was to continue to increase revenues and cash flow. To that end, as part of the annual incentive plan we granted our former CFO and COO 136,600 and 146,350 shares of restricted stock, respectively, which could have been earned if certain revenue, cash flow and individual goals were met. The number of shares granted represented approximately 50% and 60% of the CFO and COO’s 2025 base wages divided by approximately the Company’s share price on day of grant, respectively. 25% of the shares could have been earned by meeting certain revenue targets, 55% of the shares could have been earned by meeting certain results of operations targets and 20% could be earned based on meeting individual goals in fiscal year 2025. The revenue and cash flow goals had a minimum base amount, a target amount and a maximum upper goal amount. If the minimum base amount was not achieved, then no restricted stock was earned. If the minimum base amount was achieved approximately 29% of the shares could be earned, if the target amount was achieved approximately 71% of the shares could be earned and if the maximum upper goals was achieved all of the shares could be earned.

		Mr. Baker earned 86,786 of the shares granted which represents achieving approximately 85% of the Target goals and 59% of the Maximum goals.

	●	Under our long-term incentive plan Mr. Baker received restricted stock grants of 100,000 shares, of which 34% shall vest on April 23, 2026, 33% shall vest on April 23, 2027 and 33% shall vest on April 23, 2028. The restricted stock grants are subject to the Company’s 2020 Equity Incentive Plan and Mr. Baker’s continued employment by the Company. On September 2, 2025 Erich Manz became the Company’s Chief Financial Officer. In order to induce him to accept the position he was granted 400,000 shares of restricted stock. The restricted stock vests at the rate of 25% starting on December 10, 2026 and then 25% on the following three December 10ths, thereafter. Mr. Sneider, our former CFO, received a restricted stock grant of 25,000 shares that vests on April 23, 2026. The restricted stock grants are subject to the Company’s 2020 Equity Incentive Plan. These grants were issued to incentivize the individuals to remain with the Company and further align their interest with those of stockholders.

President and Chief Executive Officer:

In September 2022, Mr. Michael Murray joined Kopin as President and Chief Executive Officer. In connection with Mr. Murray’s initial employment agreement, he received (i) an initial annual base salary of $450,000, (ii). 800,000 shares of restricted stock, which vests in 20% increments each December 10 beginning in 2023, and (iii) a sign-on bonus of $100,000. A more detailed discussion of Mr. Murray’s initial employment agreement is discussed in the Employment and Other Agreements section below.

On April 15, 2024 the Company and Mr. Murray signed a new Employment Agreement (the “New Agreement”). The New Agreement was entered into to provide more specificity that was incorporated in his initial employment agreement. This summary of the New Agreement is subject to the terms of the New Agreement which is filed with the SEC as an exhibit to Form 8-K. Under the New Agreement, Mr. Murray’s salary was set at $495,000 with eligibility for a target cash bonus of 100% of base salary up to a maximum of 150% base salary based on a formula and the determination of achievement of goals as determined by the Board. Mr. Murray also is eligible for the Company’s standard benefits package and to participate in all applicable group employee benefit plans and programs offered. Mr. Murray is eligible to receive equity awards covering the Company’s common stock. Provided that Mr. Murray continues to be employed by the Company on the date of a change of control (as defined in the New Agreement), all outstanding equity awards issued as part of the 800,000 shares held by Mr. Murray immediately prior to the effective date of a change of control which vest based upon his continued service over time shall accelerate, become fully vested and/or exercisable, as the case may be, immediately prior to the change of control, and all outstanding equity awards held immediately prior to the change of control which vest based upon attainment of performance criteria shall vest based on target performance immediately prior to the change of control.

On June 28, 2024 Mr. Murray received a grant of 1,200,000 shares of restricted stock which shall vest based on the attainment of corporate performance goals and targets, including a minimum target revenue for the fiscal year 2026 of $65 million and an operating profit of 6%, and his continued employment through December 31, 2026. The target number of restricted stock that can be earned is 1,000,000. If any of the applicable performance goals are attained at less than 80% of target, the number of restricted shares earned for the portion of the 2026 Performance-Based Equity Award attributable to that performance goal will be zero. If any of the applicable performance goals are attained at between 80% and 100% of target, the number of restricted shares earned for the portion of the 2026 Performance-Based Equity Award attributable to that performance goal will be between 50% and 100% of target. If any of the applicable performance goals are attained at between 100% and 120% of target, the number of restricted shares earned for the portion of the 2026 Performance-Based Equity Award attributable to that performance goal will be between 100% and 120% of target. Performance between performance levels will be interpolated on a straight-line basis Performance achievement will be determined by the Board in its reasonable discretion exercised in good faith. Performance between performance levels will be interpolated on a straight-line basis.

Key Compensation Governance Attributes:

Our pay practices emphasize good governance and market practice:

What We Do		What We Don’t Do

✔	Stock Ownership guidelines for the CEO and Non- Employee Directors	✘	No employment agreements for anyone other than the CEO

✔	Maintain a clawback policy	✘	No excise tax gross-up provisions

✔	Emphasize pay for performance	✘	No excessive executive perquisites

✔	Annual Say on Pay advisory vote

2025 Say on Pay Vote:

●

In 2025, our stockholders voted to approve our executive compensation program (also known as “Say on Pay”) for the fourteenth time, and of the 61,741,504 votes cast, 58,245,255, or 94.3%, were in favor. The Compensation Committee considered the results of this advisory vote as it continually evaluates the Company’s compensation programs and policies to ensure that the programs strike a balance between internal (business strategy) and external (stockholder) alignment.

Compensation Philosophy

We believe that our NEOs play a critical role in the operational and financial performance of our company that creates long-term value for our stockholders. Accordingly, our executive compensation philosophy is to reward our executives for individual performance and for contributions to our corporate performance. We have invested significant efforts and funds in developing new technologies and products for both our traditional markets, military and industrial, and for the emerging “wearables” industrial market. In fiscal year 2023, our strategic emphasis shifted to improving operational excellence through a reorganization plan we refer to as One Kopin. Accordingly, we are in the process of adjusting our performance award system to be based more towards financial and operational metrics, specifically revenue growth, gross margin improvement, on-time in-full deliveries, production yields, and cash flow improvement.

We strive to counterbalance our employee retention objectives and pay-for-performance objectives. Historically we believe we have accomplished this by compensating our executives with a combination of base salary, performance restricted stock awards and long-term equity-based retention compensation. In fiscal year 2025, we maintained the same philosophy but we continued to strive to create a system that is based on a cash reward for achievement of annual goals such as revenue and cash flow milestones and using restricted stock grants for the achievement of longer- term incentives or retention purposes. We also issued restricted stock grants to certain employees for retention purposes.

We believe that the quality, commitment and performance of our executives are critical factors affecting our long-term value. Accordingly, our compensation objectives include:

	●	aligning our executive’s interests with the Company’s goals and our stockholders’ interests;

	●	attracting, retaining and motivating our executives and key employees; and

	●	rewarding individuals for their performance that enhances shareholder value.

In addition, we periodically use publicly available data and surveys and peer group comparisons to assist us in determining whether our executive compensation is appropriate in light of our compensation objectives and philosophy.

Role of the Compensation Committee

The Compensation Committee of our Board of Directors sets our executive compensation policies and determines the amounts and elements of compensation for our executive officers and Board of Directors. As set forth in the Compensation Committee’s written charter, its responsibilities include establishing compensation policies for our directors and executive officers; reviewing and approving the Chief Executive Officer’s annual compensation; approving employment agreements or arrangements with executive officers; administering our 2020 Equity Incentive Plan and legacy equity award plans (the “Equity Plans”) and approving grants under the 2020 Equity Plan; and making recommendations regarding any other incentive compensation or equity-based plans. The Compensation Committee may delegate certain authority with respect to compensation matters to our executive officers.

The Compensation Committee considers the amounts and elements of compensation for our executive officers, both for the past and the upcoming fiscal year based on the following:

	●	the Company’s next fiscal year’s forecasted development and financial results;

	●	the evaluation and performance review process; and

	●	the Compensation Committee members’ personal experience and trends identified in the peer group benchmarking analysis.

For all employees, other than our NEOs and certain executive officers and employees, the Compensation Committee approves ranges of merit increases, for example up to 5% of base salary compensation based on recommendations from the Chief Executive Officer related to compensation, other than his own compensation.

For all executive officers other than our Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, the Compensation Committee establishes and approves the base salary compensation based on recommendations from the Chief Executive Officer.

With respect to compensation of our Chief Executive Officer, the Compensation Committee establishes and approves the compensation determinations based on the Compensation Committee’s evaluation and performance reviews of our Chief Executive Officer.

A copy of the Compensation Committee charter is posted on our website, www.kopin.com, under the heading “Investors: Corporate Governance.” For the fiscal year 2025, our Compensation Committee consisted of Ms. Seif (Chairperson), Dr. Avery and Mr. Nieuwsma. All Board members who served on the Compensation Committee in 2025 were determined to be an independent director as determined by our Board, based upon the Nasdaq Rules and our independence guidelines.

The Role of Management

At the request of the Compensation Committee, NEOs of the Company may be present at Compensation Committee meetings for discussion purposes. However, they are not involved in the decisions made by the Compensation Committee regarding their compensation, nor do they have a vote on any matters brought before the Committee. The Compensation Committee meets with the Chief Executive Officer to discuss his performance and compensation package, but ultimately, decisions regarding his package are made solely based upon the Compensation Committee’s deliberations, as well as input from the independent compensation consultant, as requested. The Compensation Committee considers recommendations from the Chief Executive Officer and Chief Financial Officer, as well as input from the compensation consultant as requested, to make decisions regarding other NEOs.

Role of the Compensation Consultant

In making its determinations with respect to executive compensation, the Compensation Committee has periodically engaged the services of a compensation consultant to provide input on trends in executive compensation and to obtain an outside perspective on our executive compensation practices and assist with our peer group benchmarking analysis. The Compensation Committee does not believe a formal annual peer group assessment by an independent third party is necessary unless either internal factors, such as employee turn-over, or external factors, such as published reports in industry periodicals, indicate significant changes in executive compensation have taken place. Since 2023, Aon’s Human Capital Solutions practice, a division of Aon plc (Aon), has been engaged to review the Company’s Board of Director compensation and as the independent compensation consultant to provide the following services:

	●	Recommend changes to the peer group of comparable companies;

	●	Complete a competitive analysis of compensation for each executive utilizing comparable peer company compensation data;

	●	Provide assistance with our long-term incentive strategy; and

	●	Provide general executive compensation advice.

In addition, the Company periodically asks Aon for assistance in benchmarking the compensation and long-term incentives of the CEO and other NEOs.

The independent compensation consultant reports directly to the Compensation Committee and carries out responsibilities as assigned by the Compensation Committee. The Compensation Committee has the sole authority to retain and terminate the compensation consultant and to approve the compensation consultant’s fees and all other terms of the engagement. The Compensation Committee exercised this authority to engage Aon as its independent compensation consultant and has direct access to the compensation consultant throughout the year. Aon serves as an advisor to the Compensation Committee on topics primarily related to Board and executive compensation. Aon does not provide us with any services other than the services provided at the request of the Compensation Committee.

The Compensation Committee periodically reviews the services provided by its outside consultants and believes that Aon is independent in providing executive compensation consulting services. The Compensation Committee conducted a specific review of its relationship with Aon in preparation of the 2026 proxy statement and determined that Aon’s work for the Compensation Committee did not raise any conflicts of interest, consistent with the guidance provided under the Dodd-Frank Wall Street Reform and Consumer Protection Act, and by the SEC and the Nasdaq Capital Market (“Nasdaq”).

Compensation Determinations

In making determinations with respect to amounts and elements of executive compensation, the Compensation Committee evaluates our overall corporate performance during the fiscal year against development plans and annual budgets; evaluates the Chief Executive Officer’s achievements against the Board’s expectations; obtains input from the Chief Executive Officer on the performance reviews of the other executive officers; evaluates the potential for future contributions by each executive to our long-term success; and periodically compares our executive compensation against a benchmarking analysis of a group of peer companies. In 2025, we did a formal benchmarking analysis of our NEOs compensation for the 2025 fiscal year.

Peer Group – Board of Director Compensation

In 2025, the Compensation Committee engaged Aon to assist in selecting a new peer group with a median revenue and market capitalization size that approximated ours for the purposes of benchmarking our Board of Director compensation. Based on Aon’s structured peer group review process and recommendations the final 2025 peer group consisted of 22 companies with a headcount between 60 and 600 employees, a revenue range of $100 million to $1 billion and market capitalization in the range of $20 million to $200 million and included the following companies:

●	908 Devices	●	Immersion Corp

●	Aehr Test Systems	●	Innovation Solutions and Support

●	Amtech Systems.	●	InTEST

●	Arteris	●	KVH Industries

●	CEVA Inc	●	LightPath Technologies

●	Clearfield	●	Magnachip Semiconductor

●	Coda Octopus Group	●	NVE Corp

●	Digimarc.	●	One Stop Systems

●	Everspin Technologies	●	Ouster

●	Frequency Electronics	●	Pixelworks, Inc

●	GSI Technology	●	Quicklogic

The following companies were added to the Peer Group used to evaluate the compensation of the Board of Directors: Aehr Test Systems, Arteris, Clearfield, Frequency Electronics, Innovation Solutions and Support, KVH Industries, LighPath Technologies, Magnachip Semiconductor, and One Stop Systems. The following companies were removed from the Peer Group: Aware, eMagin Corp., Emcore, PowerFleet, Intevac Inc. and Vuzix.

Peer Group – NEO Compensation

In 2025, the Compensation Committee engaged Aon to assist in selecting a new peer group with a median revenue and market capitalization size that approximated ours for the purposes of benchmarking our Chief Executive Officer compensation. Based on Aon’s structured peer group review process and recommendations, the final 2025 peer group consisted of 22 companies with a headcount in the range of 60 to 600 employees, a trailing twelve month revenues ranging from approximately $20 million to $1 billion and market capitalization size ranging from approximately $100 million to $1 billion and included the following companies:

●	908 Devices	●	Immersion Corp.

●	Aehr Test Systems	●	Innovation Solutions and Support

●	Amtech Systems.	●	InTEST.

●	Arteris	●	KVH Industries

●	CEVA Inc	●	LightPath Technologies

●	Clearfield	●	Magnachip Semiconductor

●	Coda Octopus Group	●	NVE Corp

●	Digimarc.	●	One Stop Systems

●	Everspin Technologies	●	Ouster

●	Frequency Electronics	●	Pixelworks, Inc

●	GSI Technology	●	Quicklogic

The following companies were added to the 2025 Peer Group: Clearfield, Innovation Solutions and Support, KVH Industries, Magnachip Semiconductor and One Stop Systems. The following companies were removed from the 2025 Peer Group: Aware, Emcore, Intevac Inc., and Sono-tek.

Elements of Compensation

Our compensation program is designed to be simple, straightforward and fair. We use the following compensation and benefits elements to provide an overall competitive compensation and benefits package that is tied to creating stockholder value and supporting the execution of our business strategies:

	●	Base salary;

	●	Annual incentive (cash or restricted stock);

	●	Long-term incentives;

	●	401(k) matching contribution;

	●	Partially funded health insurance; and

	●	Employment and change-in-control agreements for the Chief Executive Officer.

The Compensation Committee does not have any formal policies for allocating compensation among salary, annual cash incentive awards and long-term incentive equity grants, short- and long-term compensation or among cash and non-cash compensation. Instead, the Compensation Committee exercises judgment to establish a total compensation program for each officer that is a mix of current, short- and long-term incentive compensation, and cash and non-cash compensation, that the Compensation Committee believes is appropriate to achieve the goals of our executive compensation program and our corporate goals and objectives. In setting the elements of compensation, the Compensation Committee considers prior compensation paid and amounts realizable from prior stock-based awards, as well as other benefits provided by the Company. The combination and allocation of the components and the target amount of each component is also influenced by the role of the executive officer, individual performance, expected contributions, market practices, and the total value of all the compensation and benefits available to the individual executive officers. The Compensation Committee reviews and considers each component for each executive officer before making compensation decisions.

Compensation Element Detail

For the fiscal year ended December 27, 2025 the elements of compensation based on the amounts in the Summary Compensation Table and expressed as a percentage of total compensation for our CEO and NEOs was as follows:

Officer	Salary⁽¹⁾			Cash Bonus			Restricted Stock and Option Awards
Michael Murray CEO		22.9	%		25.0	%		52.1	%
Paul Baker COO		50.3	%		4.2			45.5	%
Erich Manz CFO (commenced on September 2, 2025)		9.0	%		3.1			87.9	%
Richard Sneider CFO (terminated on September 1, 2025)		54.1	%		—			45.9	%

(1)

Includes “All Other Compensation” for Mr. Murray, Mr. Baker, Mr. Manz, and Mr. Sneider of $11,177, $11,002, 2,271, $11,064, respectively. Amounts represent the Company’s matching contributions under the Company’s 401(k) Plan ranging from approximately $2,100 to $10,400 per year and premiums paid for life insurance.

Salary

We believe that establishing an appropriate level of annual base salary for our executives is an important element in retaining and motivating our executive officers. In determining base salaries for our executive officers, the Compensation Committee considers the responsibilities of each position, cost of living adjustments and the skills and experience required for each job. The Compensation Committee’s determinations are influenced heavily by the evaluations and performance reviews for each executive officer by our Chief Executive Officer, as discussed above. In addition, the Compensation Committee reviews the peer group benchmarking analysis, if performed, and finally, reviews total compensation for reasonableness prior to making any final determinations.

The following table summarizes the base salaries for 2024 and 2025:

Officer	2024		2025
Mr. Murray CEO	$	495,000	$	506,191
Mr. Baker COO	$	338,184	$	348,861
Mr. Manz CFO (commencing September 2, 2025) #	$	-	$	85,385
Mr. Sneider CFO (terminating September 1, 2025) µ	$	359,520	$	269,843

# Mr. Manz’s employment with the Company commenced on September 2, 2025 and his full 12-month base salary is $300,000.

µ Represents Mr. Sneider’s base wages through his termination as CFO on September 1, 2025.

On April 23, 2025 Mr. Murray received an increase in base salary of approximately 3.5% based upon his performance, current market conditions and the increase in the cost of living and Mr. Baker and Mr. Sneider received a cost of living increase and salary adjustment of approximately 6.5% and 2%, respectively.

Annual Bonus and Incentives

For fiscal year 2025, under the terms of Mr. Murray’s employment agreement he was eligible for a target bonus of 100% of his base salary ($512,323) up to a maximum of 150% base salary based on a formula and the determination of achievement of goals as determined by the Board. For fiscal year 2025, the Board awarded Mr. Murray a bonus of $463,374 for his contribution to the Company’s overall performance. The Board also awarded Mr. Murray a bonus of $100,000 based on the successful negotiation of the strategic agreement entered into between the Company and with Theon International PLC and the equity raise.

For fiscal year 2025 Messrs. Sneider, our former CFO, and Baker received 136,600 and 146,350 shares of restricted stock, respectively, which could have been earned if fiscal year 2025 revenue target $65 million, net operating income of $5.5 million and individual goals were met. The revenue and net operating result goals had a minimum base amount, a targets amount and a maximum upper goal amount. If the minimum base amount was achieved approximately 29% of the shares could be earned, if the target amount was achieved approximately 71% of the shares could be earned and if the maximum upper goals was achieved all the shares could be earned. If the base amount was not achieved, then no restricted stock was earned.

Mr. Baker earned 86,786, respectively, of the shares granted which represents achieving approximately 59% of the goals.

Long-Term Incentives

We believe that including an equity-based incentive component of compensation is a critical tool for motivating our executives and certain employees. We believe that granting equity awards to our executives aligns executive compensation with long-term stockholder value. By awarding executive officers with equity awards that vest over time, we believe that our executive officers will have a continuing stake in our long-term success and these awards serve as an important retention program.

We weighed our total executive compensation towards restricted stock awards that either vest upon the achievement of certain milestones or vest over time. While our management can improve our financial performance through the sales of our current products, cost reduction efforts, process improvements and other short-term advancements, we believe that our executive officers’ focus on long-term achievements, particularly increasing our product and patent portfolios, will create the greatest stockholder value. We believe that by granting our executives meaningful levels of equity awards that vest both in the short-term and long-term we will achieve the proper balance between incentivizing them to focus on the current fiscal year’s results and longer- term strategies of the Company.

In determining the size of each equity award granted to our executive officers, the Compensation Committee considers:

	●	the amount previously awarded on an annual basis to the executive,

	●	recommendations from the compensation consultant,

	●	the total value of unvested equity awards held by the executive, and

	●	the executive’s overall performance, our performance during the year and the dilution to the stockholders.

Under our long-term incentive plan Mr. Baker received restricted stock grants of 100,000 shares, of which 34% shall vest on April 23, 2026, 33% shall vest on April 23, 2027 and 33% shall vest on April 23, 2028. The restricted stock grants are subject to the Company’s 2020 Equity Incentive Plan and Mr. Baker’s continued employment by the Company. On September 2, 2025 Erich Manz became the Company’s Chief Financial Officer. In order to induce him to accept the position he was granted 400,000 shares of restricted stock. The restricted stock vests at the rate of 25% starting on December 10, 2026 and then 25% on the following three December 10ths, thereafter. Mr. Sneider, our former CFO, received a restricted stock grant of 25,000 shares that vests on April 23, 2026. The restricted stock grants are subject to the Company’s 2020 Equity Incentive Plan. These grants were issued to incentivize the individuals to remain with the Company and further align their interest with those of stockholders.

In 2025 we granted our Board and employees an aggregate of 3,382,864 shares of restricted common stock of the Company of which 1,326,230 could be earned based on achieving milestones in fiscal year 2025.

Perquisites

The Company does not offer any perquisites for the exclusive benefit of the NEOs. Our healthcare, insurance and other welfare and employee-benefit programs are the same for all eligible domestic employees, including executive officers. Benefits provided include health and dental coverage, group term life insurance, disability programs and matching contributions to our 401(k) plan. We share the cost of health and welfare benefits with our employees, a cost that is dependent on the level of benefits coverage that each employee elects. The benefits provided to foreign employees are typically determined by the laws of the applicable country they reside in. We have no outstanding loans of any kind to our executive officers.

Clawback Policy

We have a Clawback Policy that provides that performance-based compensation is recoverable from an executive officer if the Board determines that an officer has engaged in knowing or intentional fraudulent or illegal conduct that caused or substantially caused the need for a restatement of the Company’s financial results. Performance-based compensation includes cash payments and any other awards pursuant to any Company incentive plan made on or after January 1, 2009 where payment was predicated on achieving certain financial results. If the Board or an authorized committee determines that any such performance-based compensation would have been at a lower amount had it been based on the restated financial results, the Company will, to the extent practicable and permitted by applicable law, seek recoupment from such officer of the portion of such performance-based compensation that is greater than that which would have been awarded or earned had such compensation been calculated on the basis of the restated financial results.

Employment and Other Agreements

In September 2022, Mr. Michael Murray joined Kopin as President and Chief Executive Officer. In connection with Mr. Murray’s hiring, his compensation was as follows: (i) Mr. Murray received an annual base salary of $450,000, (ii), Mr. Murray received 800,000 shares of restricted stock, which vests in 20% increments each December 10 beginning in 2023, and (iii) Mr. Murray received a sign-on bonus of $100,000. Mr. Murray is entitled to an annual performance-based bonus opportunity in the form of cash and long-term awards, subject to approval by the Compensation Committee. Mr. Murray also is eligible for the Company’s standard benefits package and to participate in all applicable group employee benefit plans and programs offered. In 2023, the Compensation Committee awarded Mr. Murray a $150,000 bonus for performance in 2022.

On April 15, 2024, the Company and Mr. Murray signed a new Employment Agreement (the “New Agreement”). This summary of the New Agreement is subject to the terms of the New Agreement which is filed with the SEC as an exhibit to Form 8-K. Under the New Agreement, Mr. Murray’s salary was set at $495,000 with eligibility for a target bonus of 100% of base salary up to a maximum of 150% base salary based on a formula and the determination of achievement of goals as determined by the Board. Mr. Murray also is eligible for the Company’s standard benefits package and to participate in all applicable group employee benefit plans and programs offered. Mr. Murray is eligible to receive equity awards covering the Company’s common stock. As of the effective date of the New Agreement, Mr. Murray is no longer eligible to participate in the executive stock program applicable to other senior executives of the Company. Provided that Mr. Murray continues to be employed by the Company on the date of a change of control (as defined in the New Agreement), all outstanding equity awards held by Mr. Murray immediately prior to the effective date of a change of control which vest based upon his continued service over time shall accelerate, become fully vested and/or exercisable, as the case may be, immediately prior to the change of control, and all outstanding equity awards held immediately prior to the change of control which vest based upon attainment of performance criteria shall vest based on target performance immediately prior to the change of control. For the fiscal year 2024 the Board awarded Mr. Murray a $668,000 cash bonus for performance in 2024.

Subject to continued employment on the grant date, Mr. Murray is eligible for a performance-based award with a target of 1,000,000 RSUs and a maximum 1,200,000 RSU, which will vest based on attainment of corporate performance goals and targets established by the Board in its sole discretion, after consultation with Mr. Murray and his continued employment through December 31, 2026 (“2026 Performance-Based Equity Award”). The Board has the discretion to modify the performance goals and targets during the performance period to account for certain irregular, nonrecurring or one-time items in order to maintain alignment with shareholders’ interests in the Board’s sole discretion. If any of the applicable performance goals are attained at less than 80% of target, the number of RSUs earned for the portion of the 2026 Performance-Based Equity Award attributable to that performance goal will be zero. If any of the applicable performance goals are attained at between 80% and 100% of target, the number of RSUs earned for the portion of the 2026 Performance-Based Equity Award attributable to that performance goal will be between 50% and 100% of target. If any of the applicable performance goals are attained at between 100% and 120% of target, the number of RSUs earned for the portion of the 2026 Performance-Based Equity Award attributable to that performance goal will be between 100% and 120% of target. Performance achievement will be determined by the Board in its reasonable discretion exercised in good faith in 2027 based on the audited financials for fiscal year 2026, and in no event will the 2026 Performance-Based Equity Award be earned at greater than 120% of target. Performance between performance levels for financial goals will be interpolated on a straight-line basis.

On January 3, 2025 Mr. Murray received a restricted stock grant of 408,634 which will cliff vest in January 2028. In addition, Mr. Murray received 591,366 option to purchase the Company’s common stock at a price of $1.76. 36,960 options vest each quarter through 2029. The vesting of the restricted stock and options are subject to the terms of the Company’s 2020 Equity Incentive Plan and the restricted stock and option agreements which include additional terms including a double trigger clause in the event of a change in control. Mr. Murray also was awarded cash performance bonuses in fiscal year 2025 of $100,000 related to the successful negotiation of the strategic agreement with Theon International PLC, the equity raise and certain other matters and a $463,374 cash bonus for the Company’s performance in fiscal year 2025.

The Board has discretion to grant an additional performance based equity award following the 2026 fiscal year. The Company may terminate Mr. Murray’s employment at any time without cause or Mr. Murray may terminate his employment at any time for good reason. Upon termination by the Company without cause or by Mr. Murray with good reason, whether before or after the Change of Control Protection Period (as defined in the New Agreement), if Mr. Murray executes and does not revoke a written release (as defined in the New Agreement), Mr. Murray shall be entitled to receive, in lieu of any payments under any severance plan or program for employees or executives, the following:

The Company will pay Mr. Murray an amount equal to six months of Base Salary at the rate in effect immediately prior to the termination date. Payment shall be made over the six-month period following the termination date in substantially equal installments in accordance with the Company’s normal payroll practices. Payment will begin within 60 days following the termination date, and any installments not paid between the termination date and the date of the first payment will be paid with the first payment.

Provided that he is eligible for and timely elects continuation coverage under COBRA, the Company will pay directly to the COBRA administrator the COBRA premiums required to maintain Mr. Murray’s continued health care coverage under the Company’s group health plans that he participated in on the date of termination (“COBRA Payments”). The Company will pay the COBRA Payments for the period from his termination date until the earliest to occur of (i) the end of the six-month period following the termination date; (ii) the date he becomes eligible for group health insurance coverage through a subsequent employer; or (iii) the date he ceases to be eligible for COBRA coverage for any reason (each of the events described in (ii) or (iii) a “Disqualifying Event”. Mr. Murray is required to notify the Company within five days of becoming aware that a Disqualifying Event has occurred or will occur. The COBRA health care continuation coverage period under section 4980B of the Internal Revenue Code of 1986, as amended (the “Code”), shall run concurrently with the period during which the Company pays the COBRA Payments.

The Company shall pay any earned, accrued, and owing Base Salary up until the date of termination and any benefits accrued and due under any applicable benefit plans and programs of the Company.

Notwithstanding the foregoing, upon termination by the Company without Cause or by the Mr. Murray with Good Reason on or within six months preceding or 15 months following a Change of Control (the “Change of Control Protection Period”), and provided that Mr. Murray executes and does not revoke a written Release, then he shall be entitled to receive, in lieu of certain payments or any severance plan or program for employees or executives the following:

	(a)	The Company will pay an amount equal to 12 months Base Salary at the rate in effect immediately prior to the termination date (but not less than $495,000 in the aggregate). Payment shall be made in a lump sum within 60 days following the termination date; provided that such payment shall be made in installments as set forth in Section 6(a) above over the 12-month period following the termination date if the Change of Control is not a “change in control event” as defined under section 409A of the Code and; provided further that in the event Mr. Murray’s employment is terminated as described in this Section 7 on or within six months preceding the Change of Control, payments shall commence and, effective upon the closing of the Change of Control, he shall receive any additional amount less the aggregate amount of installment payments already received.

	(b)	Provided that he is eligible for and timely elects continuation coverage under COBRA, the Company will pay the COBRA administrator the COBRA Payments for the period from his termination date until the earliest to occur of (i) the end of the 12-month period following the termination date or (ii) a Disqualifying Event. Mr. Murray is required to notify the Company within five days of becoming aware that a Disqualifying Event has occurred or will occur. The COBRA health care continuation coverage period under section 4980B of the Code shall run concurrently with the period during which the Company pays the COBRA Payments.

	(c)	The Company will pay a prorated target Annual Bonus for the year in which his termination of employment occurs, which amount will be determined by multiplying (i) the full-year target Annual Bonus for the year in which his termination of employment occurs, by (ii) a fraction, the numerator of which is the number of days during which he was employed by the Company in the fiscal year in which the termination date occurs and the denominator of which is 365. Such prorated target Annual Bonus shall be paid in a lump sum within 60 days following the termination date.

Our 2020 Equity Incentive Plan allows for the acceleration of the vesting of unvested stock options and restricted stock awards subject to a “double trigger” mechanism in the event of a change in control.

Policies Regarding Stock Ownership and Related Matters

We believe that by holding shares of our common stock and options to purchase our common stock, our executives will have interests that are more closely aligned with those of our stockholders.

The Compensation Committee grants equity-based awards, including restricted stock awards, to our executive officers and other key employees. These equity awards are generally made on an annual grant cycle in the fourth quarter of each year at a pre-established Compensation Committee meeting following the release of earnings. We also grant equity awards in the form of restricted stock awards to the non-employee members of the Board of Directors on an annual basis following their election as directors at the annual meeting of shareholders. The Compensation Committee may make off cycle equity awards from time to time on an as-needed basis as circumstances warrant. We do not time the disclosure of material non-public information for the purpose of affecting the value of executive compensation, and it is the Compensation Committee’s practice to generally avoid granting equity awards during periods in which there is undisclosed material non-public information about the Company. In fiscal year 2025, we did not grant new awards of stock options to our NEOs during the time period outlined in Item 402(x) of Regulation S-K.

We have share ownership and retention guidelines that require each director of the Company to own shares of our common stock or options to purchase shares of our common stock having an aggregate market value of at least three times the cash component of the director’s annual retainer (excluding committee retainers) for service on the Board.

In addition, the guidelines require our directors and CEO to own shares of our common stock having an aggregate market value of at least three times his or her annual base salary. Our directors and our CEO have five years from the time they become subject to the stock ownership guidelines to achieve the target ownership thresholds. In 2025, our directors and CEO met or were on track to maintain compliance with the minimum stock ownership guidelines.

We have an Insider Trading Policy that governs our officers, directors and employees. The policy imposes limits as to when and how our personnel can engage in transactions in our securities and prohibits short sales of our common stock by all our personnel. We have filed a copy of our Insider Trading Policy as an exhibit to our Form 10-K for the year ended December 27, 2025. Our Insider Trading Policy prohibits our directors and executive officers from engaging in certain hedging and derivative transactions with respect to our securities.

Mr. Murray and Mr. Baker have established Rule 10b5-1 plans with an independent broker. These plans typically govern the sale of an officer’s stock when our stock prices meet certain levels. These plans, generally, may only be adjusted during certain times of the year with the Company’s approval. Officers and directors may also sell shares outside a Rule 10b5-1 plan during open windows under our Insider Trading Policy.

Tax and Accounting Implications

As part of its role, the Compensation Committee reviews and considers the deductibility of executive compensation under Section 162(m) of the Internal Revenue Code, as amended (the “Code”), which generally disallows a tax deduction to public companies for certain compensation in excess of $1.0 million paid in any year to a company’s chief executive officer and the four other most highly compensated officers. Certain compensation, including qualified performance-based compensation, will not be subject to the deduction limitation if certain requirements are met. Although the Compensation Committee has not adopted any specific policy with respect to the application of Section 162(m), we generally seek to structure any long-term incentive compensation granted to our executive officers in a manner that is intended to avoid disallowance of deductions under Section 162(m).

Accounting for Stock-Based Compensation

As discussed in our Annual Report on Form 10-K for the fiscal year ended December 27, 2025, the accounting for stock-based awards requires the measurement and recognition of compensation expense based on the fair value of all share-based payment awards made to employees and directors, including stock options and employee stock purchases under employee stock purchase plans. We are required to account for share-based compensation transactions using a fair value method and recognize the related expense associated with share- based payments in our statement of operations. Stock-based compensation cost is measured at the accounting measurement date based on the fair value of the award and is recognized as expense over the service period, which generally represents the vesting period. The expense recognized over the service period is required to include an estimate of the awards that will be forfeited.

All employees are eligible to participate in our equity award program but the number of employees who actually participate annually has been reduced and does not typically include employees who are paid on an hourly basis.

Summary Compensation Table

The following table summarizes the total compensation for the fiscal years ended December 27, 2025 and December 28, 2024 of those persons who served as our principal executive officer, our principal financial officer and our next most highly compensated executive officer for the fiscal year ended December 27, 2025. We refer to these individuals in this proxy as our named executive officers (NEOs).

Name and Principal Position	Year		Salary ($)		Bonus ($)⁽¹⁾		Restricted Stock Awards ($)⁽²⁾		Option Awards ($)⁽³⁾		Non-equity Incentive Plan Compensation ($)⁽⁴⁾		Change in Pension Value and Non-Qualified Deferred Compensation Earnings ($)⁽⁵⁾		All Other Compensation ($)⁽⁶⁾		Total $
Michael Murray		2025	$	506,191	$	100,000	$	600,692		575,990		463,374	$	—	$	11,176	$	2,257,423
President and Chief Executive Officer		2024	$	481,155	$	226,620	$	1,007,880		—	$	668,000		—	$	7,183	$	2,390,838
Erich Manz		2025	$	85,385	$	30,000	$	856,000		—	$	—		—	$	2,271	$	973,656
Treasurer and Chief Financial Officer (Commencing September 2, 2025)
Richard A. Sneider		2025	$	269,843	$	10,000	$	228,552		—	$	—		—	$	11,064	$	519,459
Treasurer and Chief Financial Officer (terminating September 1, 2025)		2024	$	356,701	$	—	$	165,408		—	$	—		—	$	12,738	$	534,847
Paul Baker		2025	$	348,861	$	30,000	$	326,135		—	$	—		—	$	11,002	$	715,997
Chief Operating Officer of Kopin Government and Industrial and Strategic Business Officer		2024	$	330,814	$	—	$	154,338		—	$	—		—	$	12,022	$	497,174

(1)	The amount represents discretionary cash bonuses awarded by the Company. In 2024 the Company awarded Mr. Murray a bonus of $226,620 related to performance for fiscal year 2023. In 2025 the Company awarded Mr. Murray received bonuses of $463,374 for the overall performance of the Company. In 2025 the Company also awarded Mr. Murray a bonus of $100,000 for successful negotiation of the strategic agreement entered into between the Company and Theon International PLC and the equity raise. Messer. Sneider and Baker received bonuses of $10,000 and $30,000, respectively, related to successful negotiation of the strategic agreement entered into between the Company and Theon International PLC and the equity raise. Mr. Manz received a $30,000 bonus for his contributions to the fiscal year 2025 results of the Company.
(2)	Represents the aggregate fair value on the grant date of restricted stock granted in 2025 computed in accordance with FASB ASC Topic 718. The amounts in the column reflect the number of shares of restricted common stock granted in each year multiplied by the closing share price of the Company’s stock as listed on Nasdaq on the date of grant. See notes 1 and 8 of the consolidated financial statements included in our Form 10-K for the fiscal year ended December 27, 2025, regarding assumptions underlying valuation of equity awards.
(3)	Represents the aggregate fair value on the grant date of stock option granted in 2025 computed in accordance with FASB ASC Topic 718. The amounts in the column reflect the number of shares of stock options granted in each year multiplied by the fair market value of the stock option as computed under FASB ASC Topic 718 on the day of grant. See notes 1 and 8 of the consolidated financial statements included in our Form 10-K for the fiscal year ended December 27, 2025, regarding assumptions underlying valuation of equity awards.
(4)	The amounts reflect cash bonus payments earned with respect to annual incentive plans. The Company awarded Mr. Murray a cash bonus of $463,374 for the overall performance of the Company. The Company awarded Mr. Murray a bonus of $668,000 for performance related to fiscal year 2024.
(5)	The Company does not maintain any pension or non-qualified deferred compensation plan.
(6)	Includes amounts for the Company’s matching contributions under the Company’s 401(k) Plan ranging and premiums paid for life insurance. For fiscal year 2025 Messer. Murray, Manz, Sneider and Baker received $10,350, $2,077, $10,350 and $10,350, respectively, of 401(k) match and $689, $162, 595, and $544 of life insurance premiums paid for on their behalf. For fiscal year 2024 Messer. Murray, Sneider and Baker received $6,161, $10,350 and $9,882, respectively of 401(k) match and $1,021, $2,388 and $2,140 of life insurance premiums paid for on their behalf.

Perquisites and Benefits

We provide benefit programs to executive officers and to other employees. The Board and executive management believe that perquisites for executive officers should be extremely limited in scope and value. As a result, Kopin has historically given nominal perquisites to executive officers, including NEOs. The following table generally identifies such benefit plans and who may be eligible to participate

Benefit Plan	Executive Officers	Certain Managers	Full Time Domestic Employees	Full Time Foreign Employees
401(k)	Yes	Yes	Yes	Not Offered
Defined Contribution to Retirement Plan	Not Offered	Not Offered	Not Offered	Yes⁽¹⁾
Medical/Dental/ Vision Plans	Yes	Yes	Yes	Not Offered
Life and Disability Insurance⁽²⁾	Yes	Yes	Yes	Not Offered
Short Term Incentive Plan.	Yes⁽³⁾	Yes⁽³⁾	Yes⁽⁴⁾	Not Offered
Equity Incentive Plan	Yes	Yes	Yes	Not Offered
Automobile Allowance	Not Offered	Not Offered	Not Offered	Not Offered
Income Tax Planning services	Not Offered	Not Offered	Not Offered	Not Offered
Deferred Compensation Plan	Not Offered	Not Offered	Not Offered	Not Offered
Supplemental Early Retirement Plan	Not Offered	Not Offered	Not Offered	Not Offered
Employee Stock Ownership Plan	Not Offered	Not Offered	Not Offered	Not Offered
Defined Benefit Pension Plan	Not Offered	Not Offered	Not Offered	Not Offered
Financial Planning Allowance	Not Offered	Not Offered	Not Offered	Not Offered
Country Club Memberships	Not Offered	Not Offered	Not Offered	Not Offered
Dwellings for Personal Use⁽⁵⁾	Not Offered	Not Offered	Not Offered	Not Offered

(1)	Kopin’s United Kingdom subsidiary contributes to a government sponsored retirement program for its employees.
(2)	Kopin pays for life insurance equal to an employee’s base salary for domestic employees.
(3)	Kopin has a short-term incentive plan pursuant to which certain officers and certain managers are paid a bonus if they remain with the company during the next fiscal year.
(4)	The Board has historically provided for a discretionary bonus award at the end of the fiscal year for individuals who have significantly exceed their performance expectations or provided ideas that have significant benefits to the Company.
(5)	Kopin does not provide dwellings for personal use other than for temporary job relocation.

Executive Employment Agreement / Other Potential Post-Employment Compensation

Our Equity Plans have provisions that may result in the acceleration of vesting of certain equity awards as a result of a change in control. The table below summarizes the effects on the compensation of our named executive officers as if the termination of employment or change of control provisions of the Equity Plans and employment agreement were triggered on December 27, 2025.

Name	Value of Equity Awards if a Change in Control Occurs on 12/27/25⁽¹⁾		Health Care Benefits		Severance Payments
Michael Murray	$	4,888,050		—		—
Erich Manz	$	952,000		—		—
Paul Baker	$	705,313		—		—
Richard Sneider	$	503,608		—		—

(1)

Our Equity Plans provide for the acceleration of the vesting of our equity awards in the event of a change in control of the Company. The amounts in this column represent the value the executive officer would have received if there were a change of control of the Company on December 27, 2025, and their unvested restricted stock awards and options to purchase the Company’s common stock as of December 27, 2025 became vested. The restricted stock award value is computed by multiplying the number of unvested shares of restricted stock at December 27, 2025 by the closing price of the Company’s common stock on Nasdaq on December 27, 2025 ($2.38). The unvested option award value is computed by multiplying the number of options at December 27, 2025 by the intrinsic value of the option which is computed as the closing price of the Company’s common stock on Nasdaq on December 27, 2025 ($2.38) minus the exercise price of the option ($1.76).

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END

The following table discloses information concerning stock options and unvested stock awards held by our named executive officers as of December 27, 2025 pursuant to our Equity Plans.

	Option Awards										Stock Awards
Name	Number of Securities Underlying Unexercised Options (#) Exercisable		Number of Securities Underlying Unexercised Options (#) Unexercisable		Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)		Option Exercise Price ($)		Option Expiration Date		Number of Shares or Units of Stock That Have Not Vested (#)		Market Value of Shares or Units of Stock That Have Not Yet Vested ($)⁽¹⁾		Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)		Equity Incentive Plan Awards; Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)
Michael Murray		110,881		480,485		591,366	$	1.76		1/3/2035		728,634	$	1,734,149		1,200,000	$	2,856,000
Erich Manz		—		—		—		—		—		400,000	$	952,000		—	$	—
Paul Baker		—		—		—		—		—		150,000	$	357,000		146,350	$	348,313
Richard Sneider		—		—		—		—		—		75,000	$	178,500		136,600	$	325,108

(1)	Market value information is determined by multiplying the number of shares by the closing price of our common stock on Nasdaq on the last trading day of our 2025 fiscal year ($2.38 as of December 27, 2025).

Name

2024

Incentive

Plan⁽¹⁾

2025

Retention

Grant⁽²⁾

2022

Retention

Grant⁽³⁾

Total⁽⁷⁾

Michael Murray

1,200,000

408,634

320,000

1,928,634

	2025 Incentive Plan⁽⁴⁾		2025 Retention Grants⁽⁵⁾		2025 Retention Grant⁽⁶⁾		2025 Retention Grant⁽⁷⁾	2024 Retention Grant⁽⁸⁾		Total⁽⁹⁾
Erich Manz				400,000		—	—		—		400,000
Paul Baker		146,350		-		100,000	-		50,000		296,350
Richard Sneider		136,600		-			25,000		50,000		211,600

(1)	Vesting of shares will vest upon achievement of certain milestones in the Company’s fiscal year 2026.
(2)	Shares are scheduled to vest on January 5, 2028.
(3)	The original grant was 800,000 shares and they vest at the rate of 160,000 shares on each December 10th, commencing December 10, 2023.
(4)	Vesting of shares will vest upon achievement of certain milestones in the Company’s fiscal year 2025.
(5)	Shares vest at the rate of 25% starting on December 10, 2026 and then 25% on the following three December 10ths, thereafter.
(6)	Shares vest at the rate of 34% on April 23, 2026, 33% on April 23, 2027 and 33% on April 23, 2028.
(7)	Shares vest on April 23, 2026.
(8)	Shares vest at the rate of 34% on December 10, 2025, 33% on December 10, 2026 and 33% on December 10, 2027.
(9)	The employees must remain employed by the Company, except as provided in the Company’s Equity Incentive Plan, and meet certain other conditions for the shares to vest.

PAY VERSUS PERFORMANCE

As required by Item 402(v) of Regulation S-K, we are providing the following information about the relationship between the compensation actually paid to our named executive officers and the financial performance of the Company for the fiscal years listed below. The Compensation Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown.

Year	Summary Compensation Table Total for PEO– M. Murray⁽¹⁾		Compensation Actually Paid to PEO– M. Murray⁽¹⁾⁽²⁾		Average Summary Compensation Table Total for Non-PEO NEOs⁽¹⁾		Average Compensation Actually Paid to Non-PEO NEOs⁽¹⁾⁽²⁾		Value of Initial Fixed $100 Investment Based On Total Shareholder Return⁽³⁾		Net Income (Loss)
2025	$	2,257,423	$	2,850,268	$	736,371	$	927,888	$	188.71	$	2,549,249
2024	$	2,390,838	$	2,491,558	$	516,011	$	427,512	$	33.25	$	(43,877,896	)
2023	$	1,042,357	$	1,651,367	$	602,068	$	684,290	$	49.63	$	(19,748,219	)

(1)

Mr. Murray was PEO for fiscal years 2025, 2024 and 2023. The Non-PEO NEOs presented for fiscal year 2025 consists of Mr. Manz commencing with his employment on September 2, 2025, Mr. Sneider through September 1, 2025 (termination of position Chief Financial Officer and Treasurer) and Mr. Baker. The Non-PEO NEOs presented for fiscal years 2024 and 2023 consists of Mr. Sneider and Mr. Baker.

(2)	Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718.

(3)	The cumulative total shareholder return (“TSR”) measures the cumulative value of $100 invested on the last trading day before the earliest fiscal year in the table, or December 31, 2022, including the reinvestment of dividends, through and including the end of the applicable fiscal year for which TSR is calculated, or December 27, 2025, December 28, 2024, and December 30, 2023. The Company did not pay dividends in the periods presented.

For Mr. Murray:

Year	Reported Summary Compensation Table Total for PEO (Michael Murray)		Reported Value of Equity Awards^(a)			Equity Award Adjustments^(b)		Compensation Actually Paid to PEO (Michael Murray)
2025	$	2,257,423	$	(1,176,682	)	$	1,769,527	$	2,850,268
2024	$	2,390,838	$	(1,007,880	)	$	1,108,600	$	2,491,558
2023	$	1,042,357	$	(431,999	)	$	1,041,010	$	1,651,367

(a)

Represents the total of the grant date fair value of equity award reported in the “Stock Awards” column in the Summary Compensation Table for the applicable year.

(b)

The equity award adjustments include the addition (or subtraction, as applicable) of the following: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. The valuation assumptions used to calculate fair value did not materially differ from those disclosed at the time of grant. The amounts deducted or added in calculating the equity award adjustments are as follows:

Year	Year End Fair Value of Equity Award Granted during Year that Remains Unvested		Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards			Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year		Change in Fair Value of Equity Awards Granted in Prior Years that Vested in the Year			Fair Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year			Value of Dividends or other Earnings Paid on Stock Awards not Otherwise Reflected in Fair Value or Total Compensation		Total Equity Award Adjustments
2025	$	2,161,195	$	(637,201	)	$	-	$	245,533		$	—		$	—	$	1,769,527
2024	$	1,668,000	$	(328,533	)	$	-	$	(220,392	)	$	(10,475	)	$	—	$	1,108,600
2023	$	428,190	$	505,600		$	56,020	$	51,200		$	-		$	—	$	1,041,010

For the non CEO- NEOs:

Year	Average Reported Summary Compensation Table Total for Non-PEO NEOs^(a)		Average Reported Value of Equity Awards			Average Equity Award Adjustments^(b)		Average Compensation Actually Paid to Non-PEO NEOs^(b)
2025	$	736,371	$	(470,229	)	$	661,746	$	927,888
2024	$	516,011	$	(159,873	)	$	71,375	$	427,513
2023	$	602,068	$	(255,140	)	$	337,362	$	684,290

	(a)	Represents the total of the average grant date fair value of the equity awards reported in the “Stock Awards” column in the Summary Compensation Table for the applicable year for all Non-PEO NEOs.

	(b)	The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following: (i) the year- end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstan

SEC Form DEF 14A filed by Kopin Corporation